A class of immune cells push themselves into an inflammatory state by producing large quantities of a serotonin-making enzyme, a finding that could inform future treatments for asthma and other allergic disorders.
A new tool developed by a Cornell Tech team can unobtrusively monitor electronic cigarette inhalations, yielding important information for research into vaping.
New York City’s L train has resumed full service following an extensive rehabilitation project that finished six months early and $100 million under budget, thanks in part to Cornell engineers.
A Cornell Tech-led team has pioneered the use of “ghostdrivers” – cars with drivers disguised under a car seat-like hood – to assess how pedestrians across cultures might react to autonomous vehicles.
Professionals from Cayuga Health have joined their Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center counterparts to care for New Yorkers diagnosed with COVID-19.
How individuals, and health care professionals, deal with infection from SARS-CoV-2, the virus that causes COVID-19, varies depending on the severity of the infection.
COVID-19 patients experience a wide range of disease severity. Why do some people get severe and life-threatening illness, while others suffer no symptoms or just mild ones?
The Partners of Citadel and Citadel Securities have made a $2 million gift to Weill Cornell Medicine to develop new approaches to protect people from COVID-19 and identify new cases of it.
Mathematical modeling by Weill Cornell Medicine is helping to guide New York state and New York City leaders as they make decisions that could affect the trajectory of the COVID-19 pandemic.
